News (2/7/11): University of Nevada, Reno Muscular Dystrophy Treatment Work in “Better World Report”

University of Nevada, Reno MD treatment research in “Better World Report”

Tech Transfer Office inks licensing deal with Prothelia for development of muscular dystrophy therapy

Pharmacology researcher Dean Burkin’s successful work on a treatment for muscular dystrophy and the partnership created between the University of Nevada, Reno and Prothelia, Inc. to develop it, is featured in the latest “Better World Report.” The research gives new hope to patients who suffer from Duchenne muscular dystrophy, the most common form of MD.  Read the full article…>> http://tto.dri.edu/unr-release-2-3-11-dean-burkin-prothelia-better-world.pdf

Latest News

Tech Transfer Office Streamlines System to Generate Business with Higher Education
Read more…>> http://www.unr.edu/nevadanews/templates/details.aspx?articleid=5666&zoneid=8

New Protein Therapy Shows Promise for Treating Muscular Dystrophy
Read more…>> http://tto.dri.edu/unr-protein-therapy-pg78-bwp.pdf

Defense contracts strengthen economy
Read more…>> http://www.nnbw.com/ArticleRead.aspx?storyID=16286

DRI Researcher Develops Bioengineering Company
Read more…>> http://www.dri.edu/dees-news/3235-dri-researcher-develops-bioengineering-company